297 related articles for article (PubMed ID: 17935587)
1. Community pharmacies and the provision of opioid substitution services for drug misusers: changes in activity and attitudes of community pharmacists across England 1995-2005.
Sheridan J; Manning V; Ridge G; Mayet S; Strang J
Addiction; 2007 Nov; 102(11):1824-30. PubMed ID: 17935587
[TBL] [Abstract][Full Text] [Related]
2. HIV prevention and drug treatment services for drug misusers: a national study of community pharmacists' attitudes and their involvement in service specific training.
Sheridan J; Strang J; Taylor C; Barber N
Addiction; 1997 Dec; 92(12):1737-48. PubMed ID: 9581006
[TBL] [Abstract][Full Text] [Related]
3. Community pharmacy harm reduction services for drug misusers: national service delivery and professional attitude development over a decade in Scotland.
Matheson C; Bond CM; Tinelli M
J Public Health (Oxf); 2007 Dec; 29(4):350-7. PubMed ID: 17986490
[TBL] [Abstract][Full Text] [Related]
4. Problems experienced by community pharmacists delivering opioid substitution treatment in New South Wales and Victoria, Australia.
Winstock AR; Lea T; Sheridan J
Addiction; 2010 Feb; 105(2):335-42. PubMed ID: 20078490
[TBL] [Abstract][Full Text] [Related]
5. Dispensing opioid substitution treatment: practices, attitudes and intentions of community-based pharmacists.
Lawrinson P; Roche A; Terao H; Le PP
Drug Alcohol Rev; 2008 Jan; 27(1):47-53. PubMed ID: 18034381
[TBL] [Abstract][Full Text] [Related]
6. The prescribing of methadone and other opioids to addicts: national survey of GPs in England and Wales.
Strang J; Sheridan J; Hunt C; Kerr B; Gerada C; Pringle M
Br J Gen Pract; 2005 Jun; 55(515):444-51. PubMed ID: 15970068
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.
Winstock AR; Lea T; Sheridan J
Int J Drug Policy; 2008 Dec; 19(6):450-8. PubMed ID: 18359216
[TBL] [Abstract][Full Text] [Related]
8. Buprenorphine supply by community pharmacists in Victoria, Australia: perceptions, experiences and key issues identified.
Nielsen S; Dietze P; Dunlop A; Muhleisen P; Lee N; Taylor D
Drug Alcohol Rev; 2007 Mar; 26(2):143-51. PubMed ID: 17364849
[TBL] [Abstract][Full Text] [Related]
9. Community pharmacy services for drug misusers in Scotland: what difference does 5 years make?
Matheson C; Bond CM; Pitcairn J
Addiction; 2002 Nov; 97(11):1405-11. PubMed ID: 12410781
[TBL] [Abstract][Full Text] [Related]
10. The role of policy in community pharmacies' response to injection-drug use: results of a nationwide Canadian survey.
Myers T; Cockerill R; Millson M; Rankin J; Worthington C
AIDS Public Policy J; 1996; 11(2):78-88. PubMed ID: 10915241
[TBL] [Abstract][Full Text] [Related]
11. Attitudinal factors associated with community pharmacists' involvement in services for drug misusers.
Matheson C; Bond CM; Mollison J
Addiction; 1999 Sep; 94(9):1349-59. PubMed ID: 10615720
[TBL] [Abstract][Full Text] [Related]
12. Community pharmacy services for people with drug problems over two decades in Scotland: Implications for future development.
Matheson C; Thiruvothiyur M; Robertson H; Bond C
Int J Drug Policy; 2016 Jan; 27():105-12. PubMed ID: 26723885
[TBL] [Abstract][Full Text] [Related]
13. Patients' help-seeking behaviours for health problems associated with methadone and buprenorphine treatment.
Winstock AR; Lea T; Sheridan J
Drug Alcohol Rev; 2008 Jul; 27(4):393-7. PubMed ID: 18584389
[TBL] [Abstract][Full Text] [Related]
14. What is diversion of supervised buprenorphine and how common is it?
Winstock AR; Lea T; Sheridan J
J Addict Dis; 2009 Jul; 28(3):269-78. PubMed ID: 20155596
[TBL] [Abstract][Full Text] [Related]
15. The impact of community pharmacy dispensing fees on the introduction of buprenorphine - naloxone in Australia.
Winstock AR; Lea T; Ritter A
Drug Alcohol Rev; 2007 Jul; 26(4):411-6. PubMed ID: 17564877
[TBL] [Abstract][Full Text] [Related]
16. Prescribing and dispensing for drug misusers in primary care: current practice in Scotland.
Matheson C; Bond CM; Hickey F
Fam Pract; 1999 Aug; 16(4):375-9. PubMed ID: 10493708
[TBL] [Abstract][Full Text] [Related]
17. The role of pharmacies in the care of drug users: what has changed in ten years. The case of a Swiss region.
Samitca S; Huissoud T; Jeannin A; Dubois-Arber F
Eur Addict Res; 2007; 13(1):50-6. PubMed ID: 17172779
[TBL] [Abstract][Full Text] [Related]
18. [Substitution treatment for opiate dependence: survey of community pharmacies in Aquitaine].
Jeantaud I; Haramburu F; Bégaud B
Therapie; 1999; 54(2):251-5. PubMed ID: 10394262
[TBL] [Abstract][Full Text] [Related]
19. First insights into community pharmacy based buprenorphine-naloxone dispensing in Finland.
Uosukainen H; Bell JS; Laitinen K; Tacke U; Ilomäki J; Turunen JH
Int J Drug Policy; 2013 Sep; 24(5):492-7. PubMed ID: 23567099
[TBL] [Abstract][Full Text] [Related]
20. Contested space in the pharmacy: public attitudes to pharmacy harm reduction services in the West of Scotland.
Gidman W; Coomber R
Res Social Adm Pharm; 2014; 10(3):576-87. PubMed ID: 24021859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
